Massias L - Search Results

1

Oropharyngeal Bacterial Colonization after Chlorhexidine Mouthwash in Mechanically Ventilated Critically Ill Patients.

La Combe B, Mahérault AC, Messika J, Billard-Pomares T, Branger C, Landraud L, Dreyfuss D, Dib F, Massias L, Ricard JD. La Combe B, et al. Among authors: massias l. Anesthesiology. 2018 Dec;129(6):1140-1148. doi: 10.1097/ALN.0000000000002451. Anesthesiology. 2018. PMID: 30247201

2

Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.

Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L. Couffignal C, et al. Among authors: massias l. Br J Clin Pharmacol. 2014 Nov;78(5):1022-34. doi: 10.1111/bcp.12435. Br J Clin Pharmacol. 2014. PMID: 24903189 Free PMC article. Clinical Trial.

3

Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19.

Lê MP, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G. Lê MP, et al. Among authors: massias l. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01521-20. doi: 10.1128/AAC.01521-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32868327 Free PMC article.

4

Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.

Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S, Andremont A, Mentré F. Fantin B, et al. Among authors: massias l. J Infect Dis. 2009 Aug 1;200(3):390-8. doi: 10.1086/600122. J Infect Dis. 2009. PMID: 19563257 Free PMC article. Clinical Trial.

5

Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated mice.

Grall N, Massias L, Nguyen TT, Sayah-Jeanne S, Ducrot N, Chachaty E, de Gunzburg J, Andremont A. Grall N, et al. Among authors: massias l. Antimicrob Agents Chemother. 2013 Nov;57(11):5423-5. doi: 10.1128/AAC.00039-13. Epub 2013 Aug 19. Antimicrob Agents Chemother. 2013. PMID: 23959311 Free PMC article.

6

Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R. de Montmollin E, et al. Among authors: massias l. Intensive Care Med. 2014 Jul;40(7):998-1005. doi: 10.1007/s00134-014-3276-x. Epub 2014 Apr 1. Intensive Care Med. 2014. PMID: 24687298

7

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.

Burdet C, Pajot O, Couffignal C, Armand-Lefèvre L, Foucrier A, Laouénan C, Wolff M, Massias L, Mentré F. Burdet C, et al. Among authors: massias l. Eur J Clin Pharmacol. 2015 Jan;71(1):75-83. doi: 10.1007/s00228-014-1766-y. Epub 2014 Oct 21. Eur J Clin Pharmacol. 2015. PMID: 25327505 Free article. Clinical Trial.

8

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.

Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A, Da Silva D, Lasocki S, Laouénan C, Mentec H, Mentré F, Wolff M. Pajot O, et al. Among authors: massias l. J Antimicrob Chemother. 2015 May;70(5):1487-94. doi: 10.1093/jac/dku569. Epub 2015 Jan 27. J Antimicrob Chemother. 2015. PMID: 25630642

9

Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity".

Lê MP, Le Beller C, Le Hingrat Q, Jaquet P, Wicky PH, Bunel V, Massias L, Visseaux B, Messika J, Descamps D, Mal H, Timsit JF, Peytavin G. Lê MP, et al. Among authors: massias l. Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01937-20. doi: 10.1128/AAC.01937-20. Print 2020 Nov 17. Antimicrob Agents Chemother. 2020. PMID: 32988815 Free PMC article. No abstract available.

10

Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.

Allou N, Cambau E, Massias L, Chau F, Fantin B. Allou N, et al. Among authors: massias l. Antimicrob Agents Chemother. 2009 Oct;53(10):4292-7. doi: 10.1128/AAC.01664-08. Epub 2009 Jul 27. Antimicrob Agents Chemother. 2009. PMID: 19635960 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters